Literature DB >> 11033346

Regulation of APP cleavage by alpha-, beta- and gamma-secretases.

J Nunan1, D H Small.   

Abstract

Proteolytic cleavage of the amyloid protein from the amyloid protein precursor (APP) by APP secretases is a key event in Alzheimer's disease (AD) pathogenesis. alpha-Secretases cleave APP within the amyloid sequences, whereas beta- and gamma-secretases cleave on the N- and C-terminal ends respectively. The transmembrane aspartyl protease BACE has been identified as beta-secretase and several proteases (ADAM-10, TACE, PC7) may be alpha-secretases. A number of studies have suggested that presenilins could be gamma-secretases, although this remains to be demonstrated conclusively. Inhibition of beta- and gamma-secretase, or stimulation of alpha-secretase, is a rational strategy for therapeutic intervention in AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033346     DOI: 10.1016/s0014-5793(00)02076-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  129 in total

1.  Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Authors:  Kunihiro Uryu; Helmut Laurer; Tracy McIntosh; Domenico Praticò; Daniel Martinez; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease.

Authors:  Ai-Wu Xiao; Jing He; Qian Wang; Yi Luo; Yan Sun; Yan-Ping Zhou; Yang Guan; Paul J Lucassen; Jia-Pei Dai
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

3.  Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors.

Authors:  Alexandra M Nicholson; D Nicole Riherd Methner; Adriana Ferreira
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

4.  Proteolytic processing of protocadherin proteins requires endocytosis.

Authors:  Sean M Buchanan; Stefanie S Schalm; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

5.  Mass spectrometry-based screening for inhibitors of beta-amyloid protein aggregation.

Authors:  Xun Cheng; Richard B van Breemen
Journal:  Anal Chem       Date:  2005-11-01       Impact factor: 6.986

6.  GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces β-amyloid production in APPswe/PS1dE9 mice.

Authors:  Chao Liu; Zhao-Yan Cheng; Qing-Peng Xia; Yu-Hui Hu; Chen Wang; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2021-06-26       Impact factor: 4.530

7.  Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.

Authors:  Bonnie C Miller; Elizabeth A Eckman; Kumar Sambamurti; Nicole Dobbs; K Martin Chow; Christopher B Eckman; Louis B Hersh; Dwain L Thiele
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

Review 8.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

Review 9.  Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

Authors:  Hyunbum Jang; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Bruce L Kagan; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2013-02-28       Impact factor: 3.676

10.  Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans.

Authors:  Kunihiro Uryu; Xiao-Han Chen; Dan Martinez; Kevin D Browne; Victoria E Johnson; David I Graham; Virginia M-Y Lee; John Q Trojanowski; Douglas H Smith
Journal:  Exp Neurol       Date:  2007-07-10       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.